| Left ventricular unloading during extracorporeal membrane oxygenation in patients with cardiogenic shock JJ Russo, N Aleksova, I Pitcher, E Couture, S Parlow, M Faraz, S Visintini, ... Journal of the American College of Cardiology 73 (6), 654-662, 2019 | 348 | 2019 |
| Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial FK Borges, M Bhandari, E Guerra-Farfan, A Patel, A Sigamani, M Umer, ... The Lancet 395 (10225), 698-708, 2020 | 264 | 2020 |
| Association between complications and death within 30 days after noncardiac surgery J Spence, Y LeManach, MTV Chan, CY Wang, A Sigamani, D Xavier, ... Cmaj 191 (30), E830-E837, 2019 | 259 | 2019 |
| Methodological quality of COVID-19 clinical research RG Jung, P Di Santo, C Clifford, G Prosperi-Porta, S Skanes, A Hung, ... Nature communications 12 (1), 943, 2021 | 162 | 2021 |
| Transcatheter mitral valve repair in cardiogenic shock and mitral regurgitation: a patient-level, multicenter analysis RG Jung, T Simard, C Kovach, K Flint, C Don, P Di Santo, M Adamo, ... Cardiovascular Interventions 14 (1), 1-11, 2021 | 75 | 2021 |
| The risk of diarrhea and colitis in patients with advanced melanoma undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis P Tandon, S Bourassa-Blanchette, K Bishay, S Parlow, SA Laurie, ... Journal of immunotherapy 41 (3), 101-108, 2018 | 74 | 2018 |
| Lactate clearance as a surrogate for mortality in cardiogenic shock: insights from the DOREMI trial JA Marbach, P Di Santo, NK Kapur, KL Thayer, T Simard, RG Jung, ... Journal of the American Heart Association 11 (6), e023322, 2022 | 37 | 2022 |
| Transradial versus transfemoral access for percutaneous coronary intervention in ST-segment–elevation myocardial infarction: a systematic review and meta-analysis P Di Santo, T Simard, GA Wells, RG Jung, FD Ramirez, P Boland, ... Circulation: Cardiovascular Interventions 14 (3), e009994, 2021 | 29 | 2021 |
| The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial S Parlow, P Di Santo, R Mathew, RG Jung, T Simard, T Gillmore, B Mao, ... European Heart Journal Acute Cardiovascular Care 10 (7), 712-720, 2021 | 26 | 2021 |
| Long-term outcomes of cardiogenic shock complicating myocardial infarction LH Sterling, SM Fernando, R Talarico, D Qureshi, S van Diepen, ... Journal of the American College of Cardiology 82 (10), 985-995, 2023 | 22 | 2023 |
| Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial P Di Santo, R Mathew, RG Jung, T Simard, S Skanes, B Mao, FD Ramirez, ... Critical Care 25 (1), 289, 2021 | 22 | 2021 |
| Implications of myocardial infarction on management and outcome in cardiogenic shock RG Jung, P Di Santo, R Mathew, O Abdel‐Razek, S Parlow, T Simard, ... Journal of the American Heart Association 10 (21), e021570, 2021 | 21 | 2021 |
| Clinical features, sex differences and outcomes of myocardial infarction with nonobstructive coronary arteries: a registry analysis RG Jung, S Parlow, T Simard, C Chen, H Ghataura, A Kishore, A Perera, ... Coronary artery disease 32 (1), 10-16, 2021 | 20 | 2021 |
| Optimal perfusion targets in cardiogenic shock R Mathew, SM Fernando, K Hu, S Parlow, P Di Santo, D Brodie, B Hibbert JACC: Advances 1 (2), 100034, 2022 | 19 | 2022 |
| Transcatheter mitral valve repair for inotrope dependent cardiogenic shock–design and rationale of the CAPITAL MINOS trial S Parlow, P Di Santo, RG Jung, N Fam, A Czarnecki, E Horlick, ... American Heart Journal 254, 81-87, 2022 | 15 | 2022 |
| Significant valvular dysfunction and outcomes in cardiogenic shock: insights from the randomized DOREMI trial S Parlow, W Weng, P Di Santo, RG Jung, MF Lepage-Ratte, ... Canadian Journal of Cardiology 38 (8), 1211-1219, 2022 | 14 | 2022 |
| Comparative, cross-sectional study of the format, content and timing of medication safety letters issued in Canada, the USA and the UK LM Bjerre, S Parlow, D De Launay, M Hogel, CD Black, DR Mattison, ... BMJ open 8 (10), e020150, 2018 | 13 | 2018 |
| Modifiable risk factors and residual risk following coronary revascularization: insights from a regionalized dedicated follow-up clinic T Simard, RG Jung, P Di Santo, DT Harnett, O Abdel-Razek, FD Ramirez, ... Mayo Clinic Proceedings: Innovations, Quality & Outcomes 5 (6), 1138-1152, 2021 | 11 | 2021 |
| Performance of plasma adenosine as a biomarker for predicting cardiovascular risk T Simard, RG Jung, P Di Santo, FD Ramirez, A Labinaz, C Gaudet, ... Clinical and Translational Science 14 (1), 354-361, 2021 | 10 | 2021 |
| Evaluation of plasminogen activator inhibitor-1 as a biomarker of unplanned revascularization and major adverse cardiac events in coronary angiography and percutaneous coronary … RG Jung, T Simard, P Di Santo, S Dhaliwal, C Sypkes, AC Duchez, ... Thrombosis research 191, 125-133, 2020 | 9 | 2020 |
